Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab for Motivational Circuitry in Depression
NCT03006393Phase 4Completed
- Sponsor
- Emory University
- Start
- Aug 2016
- Primary completion
- Sep 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in major depressive disorder (MDD), sponsored by Emory University. Started Aug 2016; status: completed.
02
Drugs
infliximab
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03006393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006393.